Algeria

While it has only been modestly affected, Algeria’s financial sector has not been immune to the effects of the global oil price shock, which is unsurprising given the impact it has on Algeria’s broader macroeconomic climate over the past two years. The excess liquidity that had insulated the banking industry from external shocks was eroded...

With among the largest gas reserves in the world, Algeria is set to emerge as one of the largest international producers of phosphates in the coming years. Together with cheap energy prices and its close proximity to a range of markets, these factors make the country ideally suited to large-scale fertiliser production and export. Domestic...

Although the Algerian financial sector’s coverage rates remain healthy – particularly by emerging market standards – the dramatic drop in hydrocarbons receipts since 2014 has brought a swift end to more than a decade of abundant liquidity. As broad money growth contracted to near zero in 2015, banks saw their liquid assets fall to 27.2% of...

Biopharm is a pharmaceutical company founded in early 1990. In October 1991 the company began operations with the production of generic drugs. To diversify and develop its business Biopharm started to gradually adapt its organisational structure by creating five subsidiary companies. Besides the industrial production of drugs, which remains...